chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated that he has pain that radiates down his right arm and through his right back shoulder area.  He said his fingers do tingle and have some numbness at times. This began the day following his vaccine (11/23/21).  He reported these symptoms to the pharmacy on 11/26/21.  He denied trying anything to relieve the pain up until this point.  I recommended he try taking some ibuprofen over-the-counter and see if it would help with possible inflammation and to follow up with us if they didn't help.  He came back to the pharmacy on 11/30/21 with the same complaints and no relief.  He was seen at the emergency room on 11/30/21 and they diagnosed him with nerve pain following a vaccination. They prescribed him gabapentin 300 mg, lidoderm 5% patches, and diclofenac 1% gel.
faint; Heart palpitations; headache; stomachache; brusing and swelling on sight; eye brusing/brusing and swelling on sight; This serious case was reported by a consumer and described the occurrence of faint in a 56-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID 19 VACCINE for prophylaxis.   Concomitant products included thyroid bovine and buprenorphine hydrochloride + naloxone hydrochloride (Suboxone).   On 03-OCT-2023, the patient received Shingles vaccine and COVID 19 VACCINE. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced faint (Verbatim: faint) (serious criteria GSK medically significant), palpitation (Verbatim: Heart palpitations), headache (Verbatim: headache), stomach pain (Verbatim: stomachache), eye swelling (Verbatim: brusing and swelling on sight) and eye contusion (Verbatim: eye brusing/brusing and swelling on sight).  The outcome of the faint, palpitation, headache, stomach pain, eye swelling and eye contusion were not resolved.   It was unknown if the reporter considered the faint, palpitation, headache, stomach pain, eye swelling and eye contusion to be related to Shingles vaccine.     It was unknown if the company considered the faint, palpitation, headache, stomach pain, eye swelling and eye contusion to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 06-OCT-2023 The reporter stated that patient administered the shingles vaccine of unspecified manufacturer. The patient dated heart palpitation, fainted, headache, stomachache and brushing and swelling on sight. All the reported symptoms were ongoing. The patient also got the covid shot too. The symptoms were not treated. The expiry date of shingles vaccine was unknown. It was unknown if the company considered the faint, palpitation, headache, stomach pain, eye swelling and eye contusion to be related to Covid 19 vaccine.  The reporter did not consented to contact.
Headache, Fever,  chills, body ache, paralyzed to left side of body and left sided weakness  Narrative:
A patient called today to state that she had a reaction and was not sure if it was related to the Shingrix vaccine she received yesterday (01/08/2020).  She described the reaction as redness on cheeks, whole face feels hot, low grade fever (Temperature 99.1 Degree Fahrenheit). Patient stated that her temperature usually runs around 97.5 Degree Fahrenheit.  I asked her if she wanted us to contact her PCP. Patient said that she does not want us to follow up with her PCP.
Pentacel, Dtap, HIB, IPV- Dtap-IPV component of Pentacel was given alone, without the reconstitution agent.
got shingles 1 year and two days after I got the shots/suspected vaccination failure; shingles; very painful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 1 year 2 days after receiving Shingles vaccine and less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The pateint got the Shingles shot and still got the shinlges 1 years and 2 days after the shots. The shingles were very painful and would not take another shot and hope it worked for some one else. It was not any easier for the patient, but said no more shots for him/her for shingles. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Mother came in for 4 month check, stated that last vaccine 12/1/09. Patient crying for 5 hours in the evening, arms and legs seemed jerky motion. Father was watching child, not sure if any fever, but extreme irritability. Also Diarrhea x 5 days.
The pt experienced severe weakness, coughing, fever, chills. The pt required antibiotics.
pt stated her right arm started getting hot and was hurting.  It started to swell and itch that was red that was about 4x4.  She could not get it to stop itching.  She started using Benadryl cream and a 150 mg Benadryl tablet at night.  She says it is getting  better but if she touches it again that is starts itching and it is still red and irritated around the injection site.  She did not have any complications with the other 4 Moderna vax except some mild flu like symptoms after 1st dose.
64 yo female with PMHx of HTN, DM2, CAD, reactive airway disease   Complains of sudden onset of left sided facial numbness and "room spinning" dizziness that started ~ 20 mins ago after receiving her first covid vaccine. Dizziness worse when looking to the right. +nausea Took all her medications this morning.    No extremity weakness or numbness, no slurred speech, no headache.  No chest pain, no SOB. No rash, no wheezing.   O: BP 190s/60s HR wnl SpO2 wnl   Subjectively decreased sensation to left face. Otherwise negative stroke assessment.    Vertiginous symptoms provoked with EOM to the right.    No slurred speech. Normal facial movement, no paralysis. Normal finger to nose.    A/P: Needs eval in ED, EMS called
This spontaneous case reported by a consumer, describes the occurrence of dizziness (feels lightheaded when she gets up) and headache in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jun 9, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 11, 2021, patient experienced dizziness (feels lightheaded when she gets up) and headache. Patient treated with ibuprofen on Jun 13, 2021 for adverse event, at a dose of 1 tablet. At the time of the report, dizziness (feels lightheaded when she gets up) and headache outcome: unknown. Birth control pills taken as concomitant medication.
Achy; Feverish; Joint pain; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL 9267, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 26Feb2021 at 15:30 (at the age of 67-years-old)  as dose 1, single for COVID-19 immunisation. Medical history included COVID-19 from an unknown date. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient's concomitant medications were not reported. On 27Feb2021 at 16:45, the patient experienced achy, feverish, and joint pain. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering.   No follow-up attempts are possible. No further information expected.
tiredness; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), PYREXIA (fever) and CHILLS (chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness), PYREXIA (fever) and CHILLS (chills). At the time of the report, FATIGUE (tiredness), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  It was reported that after receiving Moderna primary series, the patient experienced regular symptoms, tiredness, fever, chills, those kind of things.  No treatment medications were provided.   This case was linked to MOD-2022-543630, MOD-2022-543627, MOD-2022-543615 (Patient Link).
Within 24 hours, the pt developed an injection site reaction characterized by redness, warmth, and swelling. This is one of four pts from this facility who developed an injection site reaction following receipt of vax.
Patient contacted local health unit on 4/8/19 in reference to HPV vaccine she received on 3/14/19. She states, "about a week after I got the shot, I noticed a small knot beneath the area where I got the shot. Concerned, I call my PCP and was informed that this was a common side effect reported after receiving HPV shot and it should disappear in within a week and a half but it hasn't and has gotten bigger, tender to touch and my right shoulder hurts and I can only move it to a certain point." Pt instructed to follow up with PCP and notify clinic. On 4/12/19, I spoke with patient again in reference to how she was doing and if she had seen her PCP. Pt verbalized, " Yes, I seen my PCP on 4/8/19, and they place me on an antibiotic. I've been on the antibiotic since Monday, 4/8/19 and the knot is completely gone."
Itching started on left wrist approximately  20 minutes after receiving vaccine and progressed to other arm, back, and legs.   Patient has no other complaints.  Initial blood pressure elevated 180-210 / 120-130.  Patient reports no history of hypertension.  Patient reports having taken Zyrtec approximately 30 minutes prior to receiving vaccine.  Benadryl offered, but declined by patient at this time.
Severe coughing for three or four days.  Collapsed on the floor and could not move.  Called ambulance which took him back to Hospital where he was diagnosed with Pneumonia.
Per School Health Nurse: Rash at knees. Slight headache.  Per patient: swollen wrist, slight headache, hard time breathing and vision trouble.
expired vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine administered). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.  No vial had undergone any temperature excursions. There were no adverse reactions to the vaccine as reported by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Follow up added new reporter information
Shot administered on 1-19-17 about 2:00 p.m. by nurse. By 4:00 p.m.-1-19-17 upper arm swelled in huge knot-baseball size surrounding by red ring. Extreme pain, redness, swelling spread to complete arm, down to wrist and hand, caused numbness in fingers. Extreme pain-ER visit necessary.
patient came to pharmacy 4 days after vaccination with red splotches over various body parts.  patient expects to hear back from MD shortly but wanted to inform pharmacy.  pharmacist recommended diphenhydramine to help with redness
Chills, Severe headache and body aches, heart palpitations, chest soreness.  Unable to get out of bed.
patient stated that she received the 3 doses on the Moderna vaccine; A spontaneous report was received from a pharmacist concerning a elderly (patient age :unknown) female patient, who received three doses of Moderna's COVID-19 vaccine (mRNA-1273).   The patient's medical history was not reported by the reporter. Concomitant medications were not provided by the reporter.    On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown). On an unknown date, the patient received their second  to two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection   On an unknown date, the elderly patient had received three doses of Moderna vaccine.    Treatment activities was not reported by the reporter.   Action taken with mRNA-1273 in response to the events was not applicable    The outcome of events, received three doses of Moderna vaccine was considered resolved.; Reporter's Comments: This report refers to an elderly (patient age: unknown) female patient who experienced who received three doses (Extra dose administered) for mRNA-1273 (Lot number: unknown). There were no reported AEs associated with this case of extra dose administered.
Slight fever; Chills; Lethargy; Rash; Did not feel well; This is a spontaneous report from a non-contactable consumer via a Pfizer employee. A female patient in her 60s (7 decades) received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as dose 2, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Patient did not feel well after her 2nd dose of the Pfizer Covid vaccine and experienced slight fever, chills, lethargy and a rash. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recvd vax & subsequently became pregnant during same mo;in F/U,RN indicated pt delivered a 5pound,8 ounces female w/ a polycystic kidney;
if I had had a different vaccine I may not have gotten Covid; if I had had a different vaccine I may not have gotten Covid; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  An elderly female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "if I had had a different vaccine I may not have gotten Covid". Clinical course: The reporter considered event was caused by suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a registered nurse referring to a 19 year old female patient. The patient pertinent medical history, drug reactions/allergies and concomitant medication were not provided. On 05-JUL-2016, the patient had her second dose of GARDASIL 9 (lot # M003659, expiration date 20-SEP-2017, intramuscular; dose was unknown). On 01-AUG-2016, the patient came to the office and had positive pregnancy urine test in the office. An ultrasound had not yet been performed on the patient. The last menstrual period was 15-JUN-2016 and estimated date of delivery (EDD) was 22-MAR-2017. The pregnancy outcome was pending. The outcome of the event was unknown. Additional information has been requested.
Nothing immediate. Developed what became a palpable lt. axillary mass. 6cm x 3cm x3cm approximately Mass became painful and ultimately compressed surrounding tissues including branches of the axillary nerve, and vasculature.
Pt received HPV #1 and Hep A #2. Pt was checked after 15 min wait and c/o  bad headache, dizziness and weakness.
was given 6 times the normal dose; bad headaches; brain fog; trouble breathing; weak; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 49-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Caller, female, calling on behalf of brother-in-law, he was given 6 times the normal dose of vaccine along with 71 other inmates. She's not sure what date he received the vaccine. She states it was all over the news. Both nurses have been suspended. He is still having side effects like bad headaches, brain fog, trouble breathing and is weak on an unspecified date. The prison now wants to administer a second dose to him. She is calling to whether or not if this is appropriate and wants documentation on why he shouldn't get the second dose because he got such a high dose the first time. The outcome of the events was unknown.  Information on the lot/batch number has been requested. Follow up needed, further information has been requested.  Follow-up (19Aug2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
chest tightness on 9OCT92; DPH abd pain, nausea & vomiting; 16OCT92 not much better-on Zantac, bland diet; 21OCT92 gradually improved & feeling better;
Hospital Course and Significant Findings: Per Dr. HPI 1/16/2023: 69M hx HTN, diabetes, smoldering IgG lambda myeloma, HLD, CAD, anemia, OSA who presents with a few days of abdominal pain. Patient endorses that for the past approximately 5 days he has had left lower quadrant abdominal pain, as well as nausea and vomiting.  He has been constipated for few days although he continues to pass gas.  He has had a few episodes of emesis, intermittently bilious.  He does not report any hematuria or dysuria, although he has had some suprapubic tenderness.  He also endorses he has had cough for a few days, without frank dyspnea or chest pain. Triage vitals: Temperature 102.6, heart rate 104, blood pressure 133/76, respiratory rate 23, satting 93% on room air NA 125, K4.1, chloride 91, CO2 21, creatinine 1.43, glucose 226 WBC 15.1, hemoglobin 10.9, platelets 189, 81% neutrophil T bili 1.2, FTs otherwise within normal limits Lactic acid 3.7 down to 3.2 UA with protein, large leuk esterase, moderate hemoglobin, 32 RBC, 158 WBC, bacteria present, squame present CT abdomen pelvis with left perinephric/periureteral fat stranding and urothelial enhancement.  No drainable fluid collections. Chest x-ray ordered and pending.  Blood cultures ordered and pending In the emergency department he received goal-directed 30 cc/kg fluid bolus of lactated Ringer's as well as Zosyn.  Received permission from the patient to call the patient's daughter, and discussed reasons for admission and expected hospital course.   Patient showed significant improvement and endorsed feeling much better with IV antibiotics his cultures both urine and blood grew E. coli pansensitive.  Patient's IV Zosyn was continued throughout the course of his stay and transition to Vantin 200 mg twice daily total 14 days.  Patient had some deconditioning and with ambulation had some desaturation on pulse ox empirically patient was sent home on oxygen.  On room air without activity he remained in maintain his sats over 92%.  Patient was encouraged to continue to use his CPAP for his obstructive sleep apnea at home.
Chills, fever from 5 am to 6:30 am, body aches, nausea
WBC decreased; This spontaneous case was reported by a consumer and describes the occurrence of WHITE BLOOD CELL COUNT DECREASED (WBC decreased) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L02A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included WBC decreased since January 2020. Concomitant products included FLUOXETINE, ROSUVASTATIN, AMLODIPINE, CALCIUM, VITAMIN D NOS and VITAMIN B NOS for an unknown indication.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced WHITE BLOOD CELL COUNT DECREASED (WBC decreased). At the time of the report, WHITE BLOOD CELL COUNT DECREASED (WBC decreased) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2020, Blood count (3.8-10.8): low (Low) Low. On 14-Jan-2021, Blood count (3.8-10.8): 3.7 (Low) chronic low WBC..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for the events not provided.  Patient's WBC was low and 5 months later she has performed lab test again with low results. Her treating physician referred that her WBC low was normal for her.   This case was linked to MOD-2021-018445 (Patient Link).
feeling tired; headache; feel not well; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received BNT162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 14Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 16Mar2021 (Tuesday), patient feel tired, headache, and feeling not well. Patient wanted to know if these were expected side effects and how long would they last. It was unknown if patient received any treatment for the events. The outcome of all the events was unknown.  Follow-up attempts are completed. No further information is expected.
Information has been received from a licensed professional nurse concerning a 7 year old male with allergies to penicillin and amoxil who on 12/15/97 at 11"30 was vaccinated in the left arm with a first dose of varicella virus vaccine live (lot # 623655/0807E). There were no adverse events following prior vaccinations with the patient or sibling. On 5/10/04, the patient developed under 50 lesions. Subsequently, the patient recovered. No further information is expected.
pt recv vax & devel an inj site rxn characterized by tenderness & swelling which extended below the elbow;pt seen by MD tx w/Pred & recovered;
After being vaccinated for the 2nd time with the Moderna vaccine on Feb. 27, 2021, I had an increased fever, temperature, weakness, coughing, and dizziness. All these symptoms continued for up to 2-3 days as heavy as, then gradually moved to my "normal health" after almost 7-days. During this period I took only Cetamol tablets based on the advice of my primary care physician on phone mesaging. Nowadays, I witness symptoms of tinnitus which appeared directly after the 2nd vaccine. The tinnitus was a wavy (up-down) case but it now a serious and continuous issue. This is something I did not witness or suffer from in the past. The tinnitus is impacting me a lot, and sometimes I can't sleep well.